Metabolic Syndrome features and risk of neural tube defects

<p>Abstract</p> <p>Background</p> <p>Maternal obesity and pre-pregnancy diabetes mellitus, features of the metabolic syndrome (MetSyn), are individual risk factors for neural tube defects (NTD). Whether they, in combination with additional features of MetSyn, alter this...

Full description

Bibliographic Details
Main Authors: Wong Pui-Yuen, Wyatt Philip R, Meier Chris, Vermeulen Marian J, Thompson Miles D, Ray Joel G, Summers Anne M, Farrell Sandra A, Cole David EC
Format: Article
Language:English
Published: BMC 2007-09-01
Series:BMC Pregnancy and Childbirth
Online Access:http://www.biomedcentral.com/1471-2393/7/21
_version_ 1811283002408304640
author Wong Pui-Yuen
Wyatt Philip R
Meier Chris
Vermeulen Marian J
Thompson Miles D
Ray Joel G
Summers Anne M
Farrell Sandra A
Cole David EC
author_facet Wong Pui-Yuen
Wyatt Philip R
Meier Chris
Vermeulen Marian J
Thompson Miles D
Ray Joel G
Summers Anne M
Farrell Sandra A
Cole David EC
author_sort Wong Pui-Yuen
collection DOAJ
description <p>Abstract</p> <p>Background</p> <p>Maternal obesity and pre-pregnancy diabetes mellitus, features of the metabolic syndrome (MetSyn), are individual risk factors for neural tube defects (NTD). Whether they, in combination with additional features of MetSyn, alter this risk is not known. We evaluated the risk of NTD in association with maternal features of the MetSyn.</p> <p>Methods</p> <p>We used a population-based case-control study design in the province of Ontario, Canada. Cases and controls were derived from women who underwent antenatal maternal screening (MSS) at 15 to 20 weeks' gestation. There were 89 maternal cases with, and 434 controls without, an NTD-affected singleton pregnancy. Maternal features of MetSyn were defined by the presence of pre-pregnancy diabetes mellitus, body weight ≥ 90th centile among controls, non-white ethnicity and/or serum highly sensitive C-reactive protein (hsCRP) ≥ 75th centile of controls. Since hsCRP naturally increases in pregnancy, analyses were performed with, and without, the inclusion of hsCRP in the model.</p> <p>Results</p> <p>Mean hsCRP concentrations were exceptionally high among study cases and controls (6.1 and 6.4 mg/L, respectively). When hsCRP was excluded from the model, the adjusted odds ratios for NTD were 1.9 (95% confidence interval 1.1–3.4) in the presence 1 feature of MetSyn, and 6.1 (1.1–32.9) in the presence of 2 or more features. When hsCRP was included, the respective risk estimates were attenuated to 1.6 (0.88–2.8) and 3.1 (1.2–8.3).</p> <p>Conclusion</p> <p>We found about 2-fold and 6-fold higher risk for NTD in the presence 1, and 2 or more features, of the metabolic syndrome, respectively. It is not clear whether this risk is altered by the presence of a high serum hsCRP concentration.</p>
first_indexed 2024-04-13T02:02:40Z
format Article
id doaj.art-526f90fe9e2b4d0aa4fd95ff09814cd0
institution Directory Open Access Journal
issn 1471-2393
language English
last_indexed 2024-04-13T02:02:40Z
publishDate 2007-09-01
publisher BMC
record_format Article
series BMC Pregnancy and Childbirth
spelling doaj.art-526f90fe9e2b4d0aa4fd95ff09814cd02022-12-22T03:07:34ZengBMCBMC Pregnancy and Childbirth1471-23932007-09-01712110.1186/1471-2393-7-21Metabolic Syndrome features and risk of neural tube defectsWong Pui-YuenWyatt Philip RMeier ChrisVermeulen Marian JThompson Miles DRay Joel GSummers Anne MFarrell Sandra ACole David EC<p>Abstract</p> <p>Background</p> <p>Maternal obesity and pre-pregnancy diabetes mellitus, features of the metabolic syndrome (MetSyn), are individual risk factors for neural tube defects (NTD). Whether they, in combination with additional features of MetSyn, alter this risk is not known. We evaluated the risk of NTD in association with maternal features of the MetSyn.</p> <p>Methods</p> <p>We used a population-based case-control study design in the province of Ontario, Canada. Cases and controls were derived from women who underwent antenatal maternal screening (MSS) at 15 to 20 weeks' gestation. There were 89 maternal cases with, and 434 controls without, an NTD-affected singleton pregnancy. Maternal features of MetSyn were defined by the presence of pre-pregnancy diabetes mellitus, body weight ≥ 90th centile among controls, non-white ethnicity and/or serum highly sensitive C-reactive protein (hsCRP) ≥ 75th centile of controls. Since hsCRP naturally increases in pregnancy, analyses were performed with, and without, the inclusion of hsCRP in the model.</p> <p>Results</p> <p>Mean hsCRP concentrations were exceptionally high among study cases and controls (6.1 and 6.4 mg/L, respectively). When hsCRP was excluded from the model, the adjusted odds ratios for NTD were 1.9 (95% confidence interval 1.1–3.4) in the presence 1 feature of MetSyn, and 6.1 (1.1–32.9) in the presence of 2 or more features. When hsCRP was included, the respective risk estimates were attenuated to 1.6 (0.88–2.8) and 3.1 (1.2–8.3).</p> <p>Conclusion</p> <p>We found about 2-fold and 6-fold higher risk for NTD in the presence 1, and 2 or more features, of the metabolic syndrome, respectively. It is not clear whether this risk is altered by the presence of a high serum hsCRP concentration.</p>http://www.biomedcentral.com/1471-2393/7/21
spellingShingle Wong Pui-Yuen
Wyatt Philip R
Meier Chris
Vermeulen Marian J
Thompson Miles D
Ray Joel G
Summers Anne M
Farrell Sandra A
Cole David EC
Metabolic Syndrome features and risk of neural tube defects
BMC Pregnancy and Childbirth
title Metabolic Syndrome features and risk of neural tube defects
title_full Metabolic Syndrome features and risk of neural tube defects
title_fullStr Metabolic Syndrome features and risk of neural tube defects
title_full_unstemmed Metabolic Syndrome features and risk of neural tube defects
title_short Metabolic Syndrome features and risk of neural tube defects
title_sort metabolic syndrome features and risk of neural tube defects
url http://www.biomedcentral.com/1471-2393/7/21
work_keys_str_mv AT wongpuiyuen metabolicsyndromefeaturesandriskofneuraltubedefects
AT wyattphilipr metabolicsyndromefeaturesandriskofneuraltubedefects
AT meierchris metabolicsyndromefeaturesandriskofneuraltubedefects
AT vermeulenmarianj metabolicsyndromefeaturesandriskofneuraltubedefects
AT thompsonmilesd metabolicsyndromefeaturesandriskofneuraltubedefects
AT rayjoelg metabolicsyndromefeaturesandriskofneuraltubedefects
AT summersannem metabolicsyndromefeaturesandriskofneuraltubedefects
AT farrellsandraa metabolicsyndromefeaturesandriskofneuraltubedefects
AT coledavidec metabolicsyndromefeaturesandriskofneuraltubedefects